Literature DB >> 18709553

Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases.

Rie Kakinoki1, Ryoji Kushima, Akiko Matsubara, Yasuharu Saito, Hidetoshi Okabe, Yoshihide Fujiyama, Takanori Hattori.   

Abstract

We histopathologically re-evaluated the histogenesis of gastric carcinomas from comparative studies between Helicobacter pylori-positive and H. pylori-negative cases using the gastritis score from the Updated Sydney System. The incidence of H. pylori-negative gastric carcinomas was 3.11% (12/386); they are likely to develop in the fundic gland mucosa, and show a gastric phenotype by mucin immunohistochemistry. Even in cases of completely gastric and predominantly gastric phenotypes, CDX2 protein was expressed in most cases (90.9% of pT1 and 100% of pT2-3), indicating a possibility that intestinalization of carcinoma cells occurs independently of the background mucosa. Regarding the degree of gastritis of background mucosa surrounding 143 H. pylori-positive differentiated-type adenocarcinomas, the mean score ranged from 1.497 to 1.713. Our data support the hypothesis that intestinal metaplasia is not a precancerous but a paracancerous lesion, and most gastric adenocarcinomas develop in mildly to moderately atrophic mucosa with H. pylori-infection, i.e., ongoing atrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18709553     DOI: 10.1007/s10620-008-0389-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.

Authors:  I Sasaki; T Yao; H Nawata; M Tsuneyoshi
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  MUC gene expression and histogenesis of adenocarcinoma of the stomach.

Authors:  S Tsukashita; R Kushima; M Bamba; H Sugihara; T Hattori
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

4.  Intestinalization of gastric signet ring cell carcinomas with progression.

Authors:  T Yamachika; K Inada; Y Fujimitsu; S Nakamura; Y Yamamura; T Kitou; S H Itzkowitz; J L Werther; K Miki; M Tatematsu
Journal:  Virchows Arch       Date:  1997-08       Impact factor: 4.064

5.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

6.  Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.

Authors:  Yun-Qing Bai; Hiroshi Yamamoto; Yoshimitsu Akiyama; Hiroyuki Tanaka; Touichirou Takizawa; Morio Koike; Osmar Kenji Yagi; Kiyoshi Saitoh; Kimiya Takeshita; Takehisa Iwai; Yasuhito Yuasa
Journal:  Cancer Lett       Date:  2002-02-08       Impact factor: 8.679

7.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

8.  Association between expression of sialosyl-Tn antigen and intestinalization of gastric carcinomas.

Authors:  R Kushima; S Jancic; T Hattori
Journal:  Int J Cancer       Date:  1993-12-02       Impact factor: 7.396

9.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

10.  Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas.

Authors:  Hiroshi Kawachi; Touichiro Takizawa; Yoshinobu Eishi; Shinichiro Shimizu; Jiro Kumagai; Nobuaki Funata; Morio Koike
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

View more
  18 in total

1.  A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype.

Authors:  Yoshihiko Ozaki; Hiroyuki Suto; Takuto Nosaka; Yasushi Saito; Tatsushi Naito; Kazuto Takahashi; Kazuya Ofuji; Hidetaka Matsuda; Masahiro Ohtani; Katsushi Hiramatsu; Tomoyuki Nemoto; Yoshiaki Imamura; Yasunari Nakamoto
Journal:  Clin J Gastroenterol       Date:  2015-01-08

2.  Endoscopic Detection of Gastric Carcinoma After Helicobacter pylori Eradication: More Difficult or Just Hype?

Authors:  Toshihisa Takeuchi; Kazuhide Higuchi
Journal:  Dig Dis Sci       Date:  2016-03-17       Impact factor: 3.199

3.  Gastric adenocarcinoma coexisting with a reddish semipedunculated polyp arising from Helicobacter pylori-negative normal gastric mucosa: a report of two cases.

Authors:  Yoshiaki Isono; Youichirou Baba; Katsumi Mukai; Hiroki Asakawa; Kenji Nose; Satomi Tsuruga; Tomomasa Tochio; Hiroaki Kumazawa; Hiroki Tanaka; Shimpei Matsusaki; Tomohiro Sase; Tomonori Saito; Hiroshi Okano; Hideki Toyoda
Journal:  Clin J Gastroenterol       Date:  2018-07-18

4.  Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study.

Authors:  Daisuke Chinda; Tadashi Shimoyama; Tatsuya Mikami; Tetsu Arai; Daisuke Chiba; Yoshio Sasaki; Kazuo Komai; Yoshihiko Sawada; Yoshiharu Saito; Hironobu Chiba; Shinsaku Fukuda
Journal:  J Gastroenterol       Date:  2018-01-20       Impact factor: 7.527

5.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

6.  Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area.

Authors:  Akihiro Okano; Shigeru Kato; Masaya Ohana
Journal:  Clin J Gastroenterol       Date:  2016-10-25

7.  Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.

Authors:  Priya Saju; Naoko Murata-Kamiya; Takeru Hayashi; Yoshie Senda; Lisa Nagase; Saori Noda; Keisuke Matsusaka; Sayaka Funata; Akiko Kunita; Masayuki Urabe; Yasuyuki Seto; Masashi Fukayama; Atsushi Kaneda; Masanori Hatakeyama
Journal:  Nat Microbiol       Date:  2016-03-14       Impact factor: 17.745

8.  Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection.

Authors:  Satoshi Kotani; Youichi Miyaoka; Aya Fujiwara; Kousuke Tsukano; Sayaka Ogawa; Satoshi Yamanouchi; Ryusaku Kusunoki; Hirofumi Fujishiro; Naruaki Kohge; Hideyuki Ohnuma; Yoshikazu Kinoshita
Journal:  Clin J Gastroenterol       Date:  2016-06-03

Review 9.  Gastric cancer stem cells: therapeutic targets.

Authors:  Slavica Stojnev; Miljan Krstic; Ana Ristic-Petrovic; Vladisav Stefanovic; Takanori Hattori
Journal:  Gastric Cancer       Date:  2013-04-06       Impact factor: 7.370

10.  Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers.

Authors:  Hee Jin Kim; Nayoung Kim; Hyuk Yoon; Yoon Jin Choi; Ju Yup Lee; Yong Hwan Kwon; Kichul Yoon; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Hye Seung Lee; Dong Ho Lee
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.